Search
Now showing items 1-1 of 1
Bcl-2/Bcl-xL inhibition predominantly synergistically enhances the anti-neoplastic activity of a low-dose CUSP9 repurposed drug regime against glioblastoma
Wissenschaftlicher Artikel
(Universität Ulm, 2019)